Establishment and accuracy evaluation of dexmedetomidine target controlled infusion system

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100045701

Enrollment

Unknown

Registered

2021-04-23

Start date

2021-05-01

Completion date

Unknown

Last updated

2021-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraoperative sedation

Interventions

Group 1:Intravenous infusion of dexmedetomidine at constant rate

Group 2:Target controlled infusion of dexmedetomidine

Eligibility

Sex/Gender

All

Age

18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective knee replacement surgery (stage 1) and lower extremity surgery (stage 2); 2. Age 18-55 years old, grade 1 anesthesia.

Exclusion criteria

Exclusion criteria: 1. Patients who take sedative analgesics for a long time before surgery; 2. Patients with cardiopulmonary insufficiency; 3. Pregnant or lactating patients; 4. Obese patients.

Design outcomes

Primary

Measure	Time frame
Effect chamber transport rate constant(KeO);System execution error;	—

Countries

China

Contacts

Public ContactLi Zhitao

Peking University Shenzhen Hospital

lytow@qq.com+86 15986636692

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026